StonvexLoading…
StonvexStonvexStonvexCore line items from ISSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $84.30M | $47.20M | $34.81M | $27.74M |
Operating Income | $20.07M | $9.66M | $7.36M | $7.22M |
Net Income | $15.63M | $7.00M | $6.03M | $5.52M |
EPS (Diluted) | $0.88 | $0.40 | $0.35 | $0.32 |
Total Assets | $103.36M | $82.38M | $62.96M | $34.71M |
Total Liabilities | $38.76M | $35.74M | $24.32M | $3.96M |
Cash & Equivalents | $2.69M | $538.98K | $3.10M | $17.25M |
Free Cash Flow OCF − CapEx | $6.79M | $5.14M | $1.80M | $5.93M |
Shares Outstanding | 17.83M | 17.48M | 17.42M | 17.26M |